p65 activity and ZAP-70 status predict the sensitivity of chronic lymphocytic leukemia cells to the selective IkappaB kinase inhibitor BMS-345541.

Source:http://linkedlifedata.com/resource/pubmed/id/19351760

Clin. Cancer Res. 2009 Apr 15 15 8 2767-76

Download in:

View as

Triples

General Info

PMID
19351760